Jeff Mann

Jeff Mann

SVP, General Counsel & Head of Business Development

Jeff Mann serves as the General Counsel and Head of Business Development for embecta. Jeff brings 22 years of medical device and law firm experience to embecta, including leadership in M&A, securities, corporate governance, intellectual property, commercial transactions, compliance and litigation, and he has deep roots in the medical, pharmaceutical and biotechnology sectors.

Most recently, he served as General Counsel and Corporate Secretary of Cantel Medical Corp., a global medical products company focused on infection prevention products, where he was responsible for the global legal, compliance, and environmental health and safety teams. He also led several business development projects, including the eventual sale of Cantel to Steris plc for $4.6 billion. Simultaneously, he held a year-long assignment as global leader of Cantel’s R&D team, managing a team of 130 associates based in Germany, Italy, the United Kingdom and the U.S.

Prior to Cantel, he spent 14 years with Boston Scientific Corporation in roles of increasing responsibility, including M&A, venture capital investments, SEC and corporate governance patent strategy, litigation, and business unit support for the $3 billion MedSurg group. He also served on the Board of Directors of Preventice Solutions and as Chair of its Compensation Committee.

Jeff holds a Bachelor of Science in Civil and Environmental Engineering from Lafayette College in Easton, PA, and a J.D. from Boston College Law School, magna cum laude.